NCT07335718

Brief Summary

Low back pain is a very common health problem in societies, regardless of the underlying cause. Its lifetime prevalence has been reported to be as high as 75-80%. Low back pain negatively affects the quality of life of affected individuals. In addition to diagnostic and treatment costs, it can lead to serious physical disability, resulting in loss of workforce and placing a substantial economic burden on countries. Many different factors play a role in the etiology of low back pain. According to etiology, it can be classified as idiopathic, mechanical, rheumatologic, metabolic, endocrine, infectious, neoplastic, neurologic/psychiatric disorders, and pain of visceral origin. The treatment of low back pain can be classified into medical treatment, physical therapy, percutaneous invasive interventions, and surgical intervention. TECAR therapy is also one of the treatment modalities routinely used in clinical practice. Our aim is to develop more effective physical therapy programs.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
54

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2025

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

January 2, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 13, 2026

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 15, 2026

Completed
Last Updated

January 13, 2026

Status Verified

January 1, 2026

Enrollment Period

1.1 years

First QC Date

January 2, 2026

Last Update Submit

January 2, 2026

Conditions

Lumbar Disc Herniation

Keywords

Lumbar Disc HerniationTECAR TherapyPain

Outcome Measures

Primary Outcomes (1)

  • Visual Analog Scale (VAS)

    Zero indicates no pain at all, whereas ten represents the most severe pain imaginable.

    Up to 1 month after the end of treatment

Secondary Outcomes (1)

  • Oswestry Disability Index

    Up to 1 month after the end of treatment

Study Arms (2)

TECAR Therapy

Patients with lumbar disc herniation

Device: TECAR THERAPY

sham TECAR Therapy

Patients with lumbar disc herniation

Device: TECAR Therapy

Interventions

TECAR TherapyDEVICE

TECAR therapy applied by a technician for 20 minutes per session, three days per week, for a total of six sessions

TECAR Therapy

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Patients presenting to the outpatient clinic of the Ankara Bilkent City Hospital Physical Therapy and Rehabilitation Hospital.

You may qualify if:

  • Having low back pain lasting longer than 12 weeks
  • Having a diagnosis of lumbar disc herniation (bulging, protruded, or extruded)
  • Being able to comply with the exercise program
  • Willingness to participate in the study Being between 20 and 60 years of age

You may not qualify if:

  • Being younger than 20 years or older than 60 years
  • Having a known and/or newly diagnosed malignancy
  • Presence of cardiac implants such as a pacemaker
  • Having inflammatory low back pain
  • Having absolute spinal stenosis (anteroposterior diameter of the spinal canal \< 10 mm and anteroposterior diameter of the lateral recess \< 3 mm)
  • History of surgery due to lumbar disc herniation, lumbar spinal stenosis, vertebral fracture, or similar conditions
  • Presence of lumbar spondylolisthesis
  • Patients with sequestered disc herniation
  • Patients with polyneuropathy
  • Patients with central pain following stroke
  • Patients with neurological deficits
  • Having a diagnosed neurodegenerative disease
  • Having a systemic musculoskeletal disease
  • Patients with acute deep vein thrombosis
  • Pregnancy
  • +6 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Bilkent City Hospital

Ankara, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Intervertebral Disc DisplacementPain

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal DiseasesHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsNeurologic ManifestationsSigns and Symptoms

Central Study Contacts

cemre y yılmaz

CONTACT

0312 552 60 00saymazcemre@gmail.com

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
DOCTOR

Study Record Dates

First Submitted

January 2, 2026

First Posted

January 13, 2026

Study Start

January 1, 2025

Primary Completion

February 1, 2026

Study Completion

February 15, 2026

Last Updated

January 13, 2026

Record last verified: 2026-01

Locations

TU(1)